高级搜索
丙酮酸乙酯通过下调蛋白激酶B通路抑制人胃癌细胞侵袭转移的研究[J]. 肿瘤防治研究, 2012, 39(07): 776-779. DOI: 10.3971/j.issn.1000-8578.2012.07.004
引用本文: 丙酮酸乙酯通过下调蛋白激酶B通路抑制人胃癌细胞侵袭转移的研究[J]. 肿瘤防治研究, 2012, 39(07): 776-779. DOI: 10.3971/j.issn.1000-8578.2012.07.004
Inhibitory Effects of Ethyl Pyruvate on Invasion and Metastasis of Human Gastric Cancer SGC-7901 Cells via Downregulation of Akt Pathway[J]. Cancer Research on Prevention and Treatment, 2012, 39(07): 776-779. DOI: 10.3971/j.issn.1000-8578.2012.07.004
Citation: Inhibitory Effects of Ethyl Pyruvate on Invasion and Metastasis of Human Gastric Cancer SGC-7901 Cells via Downregulation of Akt Pathway[J]. Cancer Research on Prevention and Treatment, 2012, 39(07): 776-779. DOI: 10.3971/j.issn.1000-8578.2012.07.004

丙酮酸乙酯通过下调蛋白激酶B通路抑制人胃癌细胞侵袭转移的研究

Inhibitory Effects of Ethyl Pyruvate on Invasion and Metastasis of Human Gastric Cancer SGC-7901 Cells via Downregulation of Akt Pathway

  • 摘要: 目的 探讨丙酮酸乙酯(EP)对人胃癌SGC-7901细胞侵袭转移的抑制效果及机制。方法噻唑蓝比色分析法 (MTT法)测定EP在胃癌SGC-7901细胞中的半数抑制浓度(IC50)。不同浓度EP加入到胃癌细胞后,实时定量PCR检测蛋白激酶B(Akt)的mRNA表达水平;Western blot检测Akt、p-Akt、基质金属蛋白酶-2 (MMP-2)和MMP-9的蛋白表达水平。划痕和Transwell实验评价胃癌细胞侵袭转移的能力。通过建立裸鼠皮下移植瘤模型,免疫组织化学进一步验证以上蛋白的表达水平。结果EP在胃癌SGC-7901细胞中的IC50 为36.73 mmol/L。EP抑制Akt mRNA的表达及下调Akt、p-Akt、MMP-2和MMP-9的蛋白表达。划痕实验显示EP可抑制胃癌细胞的迁移运动能力;Transwell显示,与对照组(93.33±4.16)相比,EP 10 mmol/L组(75.34±4.73)、EP 20 mmol/L组(61.34±3.06 )及EP 40 mmol/L组(39.00±3.00)的侵袭转移细胞数明显减少 (P均<0.001)。免疫组组织化学进一步证实了Western blot的检测结果。结论EP通过下调Akt通路抑制人胃癌细胞的侵袭和转移,对癌症具有一定的治疗效果。

     

    Abstract: Objective To explore the effects and molecular mechanisms of ethyl pyruvate (EP) on invasion and metastasis of human gastric cancer SGC-7901 cells. Methods MTT assay was used to evaluate IC50 of EP on human gastric cancer SGC-7901 cell line.After different concentrations of EP (0,10 mmol/L,20 mmol/L and 40mmol/L) were added into SGC-7901 cells,the expression levels of protein kinase B (Akt) and phosphorylated Akt (p-Akt) mRNA were identified by real-time PCR,and the expression levels of Akt,p-Akt,matrix metalloproteinase-2 (MMP-2) and MMP-9 protein were detected by Western blot.The invasive and metastatic activities of gastric cancer cells were evaluated by wound -healing and Transwell assay.SGC-7901 xenograft tumor model was established,and the protein expression of Akt,p -Akt,MMP-2 and MMP-9 was further validated by immunohistochemical analysis. Results The IC50 of EP on human gastric cancer SGC-7901 cells was about 36.73mmol/L.EP administration inhibited Akt mRNA expression,and downregulated Akt,p-Akt,MMP-2 and MMP-9 protein expression.Wound-healing assay indicated that the migration and exercise capability of SGC-7901 cells was reduced obviously;Transwell assay showed,in comparison with the control group (93.33±4.16),the number of invasive and metastatic cells infiltrated the matrigel in EP 10 mmol/L group(75.34±4.73),EP 20 mmol/L group (61.34±3.06) and EP 40 mmol/L group (39.00±3.00) was respectively decreased (each P<0.001).Immunohistochemical analysis further confirmed the expression levels of Akt,p-Akt,MMP-2 and MMP-9 protein shown by Western blot. Conclusion EP administration can inhibit the invasion and metastasis of human gastric cancer SGC-7901 cells via downregulation of Akt pathway,and it may play a crucial role in cancer therapy.

     

/

返回文章
返回